MolMed S.p.A


MolMed S.p.A. is an Italian biotechnology cell&gene company focused on research, development, manufacturing and clinical validation of innovative therapies in oncology and rare diseases. MolMed built an original dual business model, based on R&D on proprietary products and third parties GMP services. MolMed is currently the developer and manufacturer for worldwide leader clients in the field of gene therapy for rare diseases and allogenic CAR-T therapies, supporting their clinical trials and commercial supply. MolMed is headquartered in Milan at the San Raffaele Biotechnology Department, has an operating unit at OpenZone in Bresso (Milan area) and is listed in the Milan Stock Exchange.